These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36127575)

  • 21. Acylcarnitine analysis by tandem mass spectrometry.
    Smith EH; Matern D
    Curr Protoc Hum Genet; 2010 Jan; Chapter 17():Unit 17.8.1-20. PubMed ID: 20063265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ESI-MS/MS study of acylcarnitine profiles in urine from patients with organic acidemias and fatty acid oxidation disorders.
    Kobayashi H; Hasegawa Y; Endo M; Purevsuren J; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):80-7. PubMed ID: 17301002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative acylcarnitine determination by UHPLC-MS/MS--Going beyond tandem MS acylcarnitine "profiles".
    Minkler PE; Stoll MS; Ingalls ST; Kerner J; Hoppel CL
    Mol Genet Metab; 2015 Dec; 116(4):231-41. PubMed ID: 26458767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correcting false positive medium-chain acyl-CoA dehydrogenase deficiency results from newborn screening; synthesis, purification, and standardization of branched-chain C8 acylcarnitines for use in their selective and accurate absolute quantitation by UHPLC-MS/MS.
    Minkler PE; Stoll MSK; Ingalls ST; Hoppel CL
    Mol Genet Metab; 2017 Apr; 120(4):363-369. PubMed ID: 28190699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids.
    Yuasa M; Hata I; Sugihara K; Isozaki Y; Ohshima Y; Hara K; Tajima G; Shigematsu Y
    Dis Markers; 2019; 2019():2984747. PubMed ID: 30881520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substrate specificity of human carnitine acetyltransferase: Implications for fatty acid and branched-chain amino acid metabolism.
    Violante S; Ijlst L; Ruiter J; Koster J; van Lenthe H; Duran M; de Almeida IT; Wanders RJ; Houten SM; Ventura FV
    Biochim Biophys Acta; 2013 Jun; 1832(6):773-9. PubMed ID: 23485643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of carnitine esters by radio-high performance liquid chromatography in cultured skin fibroblasts from patients with mitochondrial fatty acid oxidation disorders.
    Schmidt-Sommerfeld E; Bobrowski PJ; Penn D; Rhead WJ; Wanders RJ; Bennett MJ
    Pediatr Res; 1998 Aug; 44(2):210-4. PubMed ID: 9702916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of carnitine in intracellular metabolism.
    Bremer J
    J Clin Chem Clin Biochem; 1990 May; 28(5):297-301. PubMed ID: 2199593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple acyl-CoA-dehydrogenase deficiency (MADD): use of acylcarnitines and fatty acids to monitor the response to dietary treatment.
    Abdenur JE; Chamoles NA; Schenone AB; Jorge L; Guinle A; Bernard C; Levandovskiy V; Fusta M; Lavorgna S
    Pediatr Res; 2001 Jul; 50(1):61-6. PubMed ID: 11420420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous quantification of acylcarnitine isomers containing dicarboxylic acylcarnitines in human serum and urine by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Maeda Y; Ito T; Suzuki A; Kurono Y; Ueta A; Yokoi K; Sumi S; Togari H; Sugiyama N
    Rapid Commun Mass Spectrom; 2007; 21(5):799-806. PubMed ID: 17279485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Separation and identification of underivatized plasma acylcarnitine isomers using liquid chromatography-tandem mass spectrometry for the differential diagnosis of organic acidemias and fatty acid oxidation defects.
    Peng M; Fang X; Huang Y; Cai Y; Liang C; Lin R; Liu L
    J Chromatogr A; 2013 Dec; 1319():97-106. PubMed ID: 24169039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An LC-MS/MS method to quantify acylcarnitine species including isomeric and odd-numbered forms in plasma and tissues.
    Giesbertz P; Ecker J; Haag A; Spanier B; Daniel H
    J Lipid Res; 2015 Oct; 56(10):2029-39. PubMed ID: 26239049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of urinary acylcarnitines using gas chromatography-mass spectrometry: preliminary clinical applications.
    Lowes S; Rose ME; Mills GA; Pollitt RJ
    J Chromatogr; 1992 Jun; 577(2):205-14. PubMed ID: 1400753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of short- and medium-chain organic acids, acylcarnitines, and acyl-CoAs on mitochondrial energy metabolism.
    Sauer SW; Okun JG; Hoffmann GF; Koelker S; Morath MA
    Biochim Biophys Acta; 2008 Oct; 1777(10):1276-82. PubMed ID: 18582432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inborn errors of metabolism detectable by tandem mass spectrometry in Beijing.
    Yang N; Gong LF; Zhao JQ; Yang HH; Ma ZJ; Liu W; Wan ZH; Kong YY
    J Pediatr Endocrinol Metab; 2020 May; 33(5):639-645. PubMed ID: 32304307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screening.
    Shibata N; Hasegawa Y; Yamada K; Kobayashi H; Purevsuren J; Yang Y; Dung VC; Khanh NN; Verma IC; Bijarnia-Mahay S; Lee DH; Niu DM; Hoffmann GF; Shigematsu Y; Fukao T; Fukuda S; Taketani T; Yamaguchi S
    Mol Genet Metab Rep; 2018 Sep; 16():5-10. PubMed ID: 29946514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid quantitative analysis of carnitine and acylcarnitines by ultra-high performance-hydrophilic interaction liquid chromatography-tandem mass spectrometry.
    Kivilompolo M; Öhrnberg L; Orešič M; Hyötyläinen T
    J Chromatogr A; 2013 May; 1292():189-94. PubMed ID: 23336946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
    Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
    Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary medium-chain acylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency, medium-chain triglyceride feeding and valproic acid therapy: sensitivity and specificity of the radioisotopic exchange/high performance liquid chromatography method.
    Schmidt-Sommerfeld E; Penn D; Rinaldo P; Kossak D; Li BU; Huang ZH; Gage DA
    Pediatr Res; 1992 Jun; 31(6):545-51. PubMed ID: 1635814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening and follow-up results of fatty acid oxidative metabolism disorders in 608 818 newborns in Jining, Shandong province.
    Yang C; Shi C; Zhou C; Wan Q; Zhou Y; Chen X; Jin X; Huang C; Xu P
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 50(4):472-480. PubMed ID: 34704412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.